Publications by authors named "Xing-Xing He"

Claim this Profile
L
Lenvatinib promotes hepatocellular carcinoma pyroptosis by regulating GSDME palmitoylation.
Yuan Yuan, Mu-Ru Wang, Yang Ding, Ya Lin, Ting-Ting Xu, Xing-Xing He

Cancer Biol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global and Country-Level Analysis of Liver Cancer: Disease Burden and Recent Trends.
Luan Chen, Jie Zhang, Jing-Yi Peng, Yuan Yuan, Yang Ding, Xing-Xing He

Curr Med Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of new pesticide candidates from nature: design, synthesis and bioactivity research of rutaecarpine derivatives.
Miao-Miao Chen, Xin Guo, Tai-Qing Li, Xing-Xing He, De-Ya Wen, Xing-Chen Hang, Zheng-Hong Zhou

Pest Manag Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma.
Fan Gao, Yuan Yuan, Yang Ding, Pei-Yuan Li, Ying Chang, Xing-Xing He

Curr Med Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials.
Xing-Xing He, Da-Wei Ye

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Empirical Study of Economic Cycle, Air Quality, and National Health Since Reform and Opening Up.
Kuang-Cheng Chai, Qiang Li, Xing-Li Bao, Jiawei Zhu, Xing-Xing He

Front Public Health· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets.
Xiang-Yuan Luo, Kong-Ming Wu, Xing-Xing He

J Exp Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma.
Jia-Qi Sheng, Mu-Ru Wang, Dan Fang, Lian Liu, Wen-Jie Huang, Xing-Xing He

Biomed Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of managerial overconfidence on abnormal audit fee: From the perspective of balance mechanism of shareholders.
Xing-Xing He, De-Cong Xie, Ze-Min Hu, Xing-Li Bao, Lin Li

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
Hai-Dan Zhu, Lian Liu, Huan Deng, Zheng-Bo Li, Jia-Qi Sheng, Xing-Xing He

J Cell Physiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Cilia Blockage Promotes the Malignant Behaviors of Hepatocellular Carcinoma via Induction of Autophagy.
Lian Liu, Jia-Qi Sheng, Mu-Ru Wang, Yun Gan, Xiao-Li Wu, Xing-Xing He

Biomed Res Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of YWHAZ in cancer: A maze of opportunities and challenges.
Yun Gan, Feng Ye, Xing-Xing He

J Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer.
Fei Xu, Jing-Jun Yan, Yun Gan, Ying Chang, Hong-Ling Wang, Xing-Xing He

Mol Ther Nucleic Acids· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic perturbations of post-load hyperglycemia vs. fasting hyperglycemia.
Jing-Yi Lu, Jia-Hui Peng, Xiao-Jing Ma, Yi-Nan Zhang, Wei Zhu, Xing-Xing He

Acta Pharmacol Sin· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
Juan-Feng Zhao, Qiu Zhao, Hui Hu, Jia-Zhi Liao, Ju-Sheng Lin, Xing-Xing He

Mol Ther Nucleic Acids· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy inhibition enhanced 5‑FU‑induced cell death in human gastric carcinoma BGC‑823 cells.
Xing-Xing He, Chen-Kai Huang, Bu-Shan Xie

Mol Med Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux.
Cong Liu, Lian Liu, Hai-Dan Zhu, Jia-Qi Sheng, Xiao-Li Wu, Xing-Xing He

Sci Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of autophagy in hepatocellular carcinoma: friend or foe.
Lian Liu, Jia-Zhi Liao, Xing-Xing He, Pei-Yuan Li

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.
Yin-Ping Fan, Jia-Zhi Liao, Ya-Qi Lu, De-An Tian, Feng Ye, Xing-Xing He

Mol Ther Nucleic Acids· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.
Jing-Jun Yan, Ying Chang, Yu-Nan Zhang, Ju-Sheng Lin, Xing-Xing He

Oncol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Fei Xu, Jia-Zhi Liao, Guang-Ya Xiang, Peng-Xuan Zhao, Feng Ye, Xing-Xing He

Cancer Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
Hui-Ying Xue, Yong Liu, Jia-Zhi Liao, Ju-Sheng Lin, Bin Li, Xing-Xing He

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
Jing-Jun Yan, Yu-Nan Zhang, Jia-Zhi Liao, Kun-peng Ke, Ying Chang, Ju-Sheng Lin, Xing-Xing He

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models of liver cancer: Progress and recommendations.
Li He, De-An Tian, Pei-Yuan Li, Xing-Xing He

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer.
Qian Wu, Hua Qin, Qiu Zhao, Xing-Xing He

Biomed Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis